MedTrace Logo

The Impact of Cardiac Rehabilitation Participation on Cardiac Syndrome X

NCT00123617 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2015-04-22

No results posted yet for this study

Summary

The study is designed to test the hypothesis that participation in a standard phase III group based cardiac rehabilitation programme will improve psychological morbidity, quality of life and cardiovascular risk factors, along with chest pain severity and frequency in women with cardiac syndrome X.

Conditions

  • Microvascular Angina

Interventions

PROCEDURE

Phase III group-based cardiac rehabilitation

Phase III group-based cardiac rehabilitation

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • National Heart and Lung Institute

    lead OTHER

Principal Investigators

  • Peter Collins, MD FRCP · National Heart and Lung Institute, Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2005-05-31
Completion
2005-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00123617 on ClinicalTrials.gov